Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Van Cutsem

Showing results (141-150 of 499) with videos related to

Pageof 50
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 15, 2009
Double blind randomized phase II study with radiation+5-fluorouracil+/-celecoxib for resectable rectal cancerAnnelies Debucquoy, Sarah Roels, Laurence Goethals, et al.
Acta Gastro-Enterologica Belgica|November 23, 2011
The genetics of familial adenomatous polyposis (FAP) and MutYH-associated polyposis (MAP)Kathleen Claes, Karin Dahan, S Tejpar, et al.
Molecular Cancer Therapeutics|May 30, 2006
Chemotherapy-induced epidermal growth factor receptor activation determines response to combined gefitinib/chemotherapy treatment in non-small cell lung cancer cellsSandra Van Schaeybroeck, Joan Kyula, Donal M Kelly, et al.
Future Oncology (London, England)|May 12, 2021
KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinomaJosep Tabernero, Yung-Jue Bang, Eric Van Cutsem, et al.
Clinical Colorectal Cancer|August 28, 2013
Comparison of KRAS genotype: therascreen assay vs. LNA-mediated qPCR clamping assayShao-Chun Chang, Jonathan Denne, Luping Zhao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
Predicting the tumor response to chemoradiotherapy for rectal cancer: Model development and external validation using MRI radiomicsPhilippe Bulens, Alice Couwenberg, Martijn Intven, et al.
Annals of Surgical Oncology|March 8, 2012
The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical studyDaphne Hompes, André D'Hoore, Eric Van Cutsem, et al.
ESMO Open|August 21, 2020
Effect of trifluridine/tipiracil in patients treated in RECOURSE by prognostic factors at baseline: an exploratory analysisJosep Tabernero, Guillem Argiles, Alberto F Sobrero, et al.
European Journal of Cancer (Oxford, England : 1990)|August 19, 2007
Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomachPernilla Lagergren, Peter Fayers, Thierry Conroy, et al.
EJNMMI Research|August 16, 2020
Quantitative comparison of pre-treatment predictive and post-treatment measured dosimetry for selective internal radiation therapy using cone-beam CT for tumor and liver perfusion territory definitionEsmaeel Jafargholi Rangraz, Xikai Tang, Charlotte Van Laeken, et al.
Pageof 50

Showing results (141-150 of 499) with videos related to

Sort By:
Pageof 50
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 15, 2009
Double blind randomized phase II study with radiation+5-fluorouracil+/-celecoxib for resectable rectal cancerAnnelies Debucquoy, Sarah Roels, Laurence Goethals, et al.
Acta Gastro-Enterologica Belgica|November 23, 2011
The genetics of familial adenomatous polyposis (FAP) and MutYH-associated polyposis (MAP)Kathleen Claes, Karin Dahan, S Tejpar, et al.
Molecular Cancer Therapeutics|May 30, 2006
Chemotherapy-induced epidermal growth factor receptor activation determines response to combined gefitinib/chemotherapy treatment in non-small cell lung cancer cellsSandra Van Schaeybroeck, Joan Kyula, Donal M Kelly, et al.
Future Oncology (London, England)|May 12, 2021
KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinomaJosep Tabernero, Yung-Jue Bang, Eric Van Cutsem, et al.
Clinical Colorectal Cancer|August 28, 2013
Comparison of KRAS genotype: therascreen assay vs. LNA-mediated qPCR clamping assayShao-Chun Chang, Jonathan Denne, Luping Zhao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
Predicting the tumor response to chemoradiotherapy for rectal cancer: Model development and external validation using MRI radiomicsPhilippe Bulens, Alice Couwenberg, Martijn Intven, et al.
Annals of Surgical Oncology|March 8, 2012
The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical studyDaphne Hompes, André D'Hoore, Eric Van Cutsem, et al.
ESMO Open|August 21, 2020
Effect of trifluridine/tipiracil in patients treated in RECOURSE by prognostic factors at baseline: an exploratory analysisJosep Tabernero, Guillem Argiles, Alberto F Sobrero, et al.
European Journal of Cancer (Oxford, England : 1990)|August 19, 2007
Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomachPernilla Lagergren, Peter Fayers, Thierry Conroy, et al.
EJNMMI Research|August 16, 2020
Quantitative comparison of pre-treatment predictive and post-treatment measured dosimetry for selective internal radiation therapy using cone-beam CT for tumor and liver perfusion territory definitionEsmaeel Jafargholi Rangraz, Xikai Tang, Charlotte Van Laeken, et al.
Pageof 50